These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23337910)
1. EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells. Park JS; Khoi PN; Joo YE; Lee YH; Lang SA; Stoeltzing O; Jung YD Int J Oncol; 2013 Mar; 42(3):1120-6. PubMed ID: 23337910 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cells. Lee KE; Park JS; Khoi PN; Joo YE; Lee YH; Jung YD J Cell Biochem; 2012 Apr; 113(4):1217-23. PubMed ID: 22095683 [TBL] [Abstract][Full Text] [Related]
3. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells. Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479 [TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells. Park JS; Park JH; Lee S; Joo YE; Jung YD Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells. Khoi PN; Li S; Thuan UT; Sah DK; Kang TW; Nguyen TT; Lian S; Xia Y; Jung YD Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906413 [TBL] [Abstract][Full Text] [Related]
6. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Kim HS; Kim MH; Jeong M; Hwang YS; Lim SH; Shin BA; Ahn BW; Jung YD Anticancer Res; 2004; 24(2B):747-53. PubMed ID: 15161022 [TBL] [Abstract][Full Text] [Related]
7. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells. Park JS; Park JH; Khoi PN; Joo YE; Jung YD Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472 [TBL] [Abstract][Full Text] [Related]
8. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer. Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757 [TBL] [Abstract][Full Text] [Related]
9. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. Thangasamy A; Rogge J; Ammanamanchi S J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182 [TBL] [Abstract][Full Text] [Related]
10. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Fu Y; Chen A Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517 [TBL] [Abstract][Full Text] [Related]
11. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102 [TBL] [Abstract][Full Text] [Related]
12. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin. Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. Wang J; Rajput A; Kan JL; Rose R; Liu XQ; Kuropatwinski K; Hauser J; Beko A; Dominquez I; Sharratt EA; Brattain L; Levea C; Sun FL; Keane DM; Gibson NW; Brattain MG J Biol Chem; 2009 Apr; 284(16):10912-22. PubMed ID: 19224914 [TBL] [Abstract][Full Text] [Related]
14. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Moon Y; Lee M; Yang H Biochem Pharmacol; 2007 Jan; 73(1):125-35. PubMed ID: 17014826 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo. Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492 [TBL] [Abstract][Full Text] [Related]
16. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism]. Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512 [TBL] [Abstract][Full Text] [Related]
17. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer. Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783 [TBL] [Abstract][Full Text] [Related]
18. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma. Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326 [TBL] [Abstract][Full Text] [Related]
19. Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer. Wang Z; Yang Y; Hu S; He J; Wu Z; Qi Z; Huang M; Liu R; Lin Y; Tan C; Xu M; Zhang Z Cell Biol Toxicol; 2021 Feb; 37(1):35-49. PubMed ID: 32399910 [TBL] [Abstract][Full Text] [Related]
20. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]